Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 995-1003

  Sims Mourtada, J ^a,c   Niamat, Rohina A ^b   Samuel, Shani ^a   Eskridge, Chris ^a   Kmiec, Eric B ^a,b  

^a HELEN F GRAHAM CANCER CENTER   (United States)

^b DELAWARE STATE UNIVERSITY   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Breast cancer; Chemoresistance; Mammary stem cells; Nanofibers; Three dimensional culture

Indexed keywords

CHITOSAN; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; DOCETAXEL; DOXORUBICIN; NANOFIBER; POLYESTER; TAXOID; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; MICROSCOPY; MOLECULAR DYNAMICS; MOLECULAR SIZE; NANOANALYSIS; PHYSICAL CHEMISTRY; BREAST NEOPLASMS; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; MCF 7 CELL LINE; METABOLISM; NANOMEDICINE; PATHOLOGY; PROCEDURES; TISSUE SCAFFOLD; TUMOR CELL LINE; TUMOR STEM CELL ASSAY; ULTRASTRUCTURE;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MCF-7 CELLS; NANOFIBERS; NANOMEDICINE; NEOPLASTIC STEM CELLS; POLYESTERS; TAXOIDS; TISSUE SCAFFOLDS; TUMOR STEM CELL ASSAY;

EID: 84896836552     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S55720     Document Type: Article

References (45)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983-3988.
2. Clarke MF. Self-renewal and solid-tumor stem cells. Biol Blood Marrow Transplant. 2005;11(2 Suppl 2):14-16.
3. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100(9): 672-679.
4. Tanei T, Morimoto K, Shimazu K, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res. 2009;15(12):4234-4241.
5. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008;10(2):R25.
6. Tsuyada A, Chow A, Wu J, et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res. 2012;72(11):2768-2779.
7. Ghajar CM, Bissell MJ. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem Cell Biol. 2008;130(6):1105-1118.
8. Hale JS, Li M, Lathia JD. The malignant social network: cell-cell adhesion and communication in cancer stem cells. Cell Adh Migr. 2012;6(4): 346-355.
9. Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng. 2006;12(5):1197-1211.
10. McLane JS, Schaub NJ, Gilbert RJ, Ligon LA. Electrospun nanofiber scaffolds for investigating cell-matrix adhesion. Methods Mol Biol. 2013;1046:371-388.
11. Jahani H, Kaviani S, Hassanpour-Ezatti M, Soleimani M, Kaviani Z, Zonoubi Z. The effect of aligned and random electrospun fibrous scaf-folds on rat mesenchymal stem cell proliferation. Cell J. 2012;14(1): 31-38.
12. Szentivanyi A, Chakradeo T, Zernetsch H, Glasmacher B. Electrospun cellular microenvironments: understanding controlled release and scaf-fold structure. Adv Drug Deliv Rev. 2011;63(4-5):209-220.
13. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of collagen nanofibers. Biomacromolecules. 2002;3(2):232-238.
14. Thomas V, Zhang X, Vohra YK. A biomimetic tubular scaffold with spatially designed nanofibers of protein/PDS bio-blends. Biotechnol Bioeng. 2009;104(5):1025-1033.
15. Balasubramanian P, Prabhakaran MP, Kai D, Ramakrishna S. Human cardiomyocyte interaction with electrospun fibrinogen/gelatin nanofibers for myocardial regeneration. J Biomater Sci Polym Ed. 2013;24(14):1660-1675.
16. Duan H, Feng B, Guo X, et al. Engineering of epidermis skin grafts using electrospun nanofibrous gelatin/polycaprolactone membranes. Int J Nanomedicine. 2013;8:2077-2084.
17. Sreerekha PR, Menon D, Nair SV, Chennazhi KP. Fabrication of electrospun poly (lactide-co-glycolide)-fibrin multiscale scaffold for myocardial regeneration in vitro. Tissue Eng Part A. 2013;19(7-8): 849-859.
18. Li AD, Sun ZZ, Zhou M, et al. Electrospun chitosan-graft-PLGA nanofibres with significantly enhanced hydrophilicity and improved mechanical property. Colloids Surf B Biointerfaces. 2013;102: 674-681.
19. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004;25(26):5735-5742.
20. Zhang Y, Venugopal JR, El-Turki A, Ramakrishna S, Su B, Lim CT. Electrospun biomimetic nanocomposite nanofibers of hydroxyapatite/chitosan for bone tissue engineering. Biomaterials. 2008;29(32): 4314-4322.
21. Jayakumar R, Prabaharan M, Nair SV, Tamura H. Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv. 2010;28(1):142-150.
22. Sarasam A, Madihally SV. Characterization of chitosan-polycaprolactone blends for tissue engineering applications. Biomaterials. 2005;26(27): 5500-5508.
23. Geng X, Kwon OH, Jang J. Electrospinning of chitosan dissolved in concentrated acetic acid solution. Biomaterials. 2005;26(27): 5427-5432.
24. Borjigin M, Eskridge C, Niamat R, Strouse B, Bialk P, Kmiec EB. Electrospun fiber membranes enable proliferation of genetically modified cells. Int J Nanomedicine. 2013;8:855-864.
25. Dhiman HK, Ray AR, Panda AK. Three-dimensional chitosan scaffold- based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials. 2005;26(9):979-986.
26. Yang F, Both SK, Yang X, Walboomers XF, Jansen JA. Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application. Acta Biomater. 2009;5(9):3295-3304.
27. Chuthapisith S, Eremin J, El-Sheemey M, Eremin O. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol. 2010;19(1):27-32.
28. Lee HE, Kim JH, Kim YJ, et al. An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Br J Cancer. 2011;104(11):1730-1738.
29. Adamczyk A, Niemiec JA, Ambicka A, Mucha-Malecka A, Mitus J, Rys J. CD44/CD24 as potential prognostic markers in node-positive inva- sive ductal breast cancer patients treated with adjuvant chemotherapy. World J Surg Oncol. 2013;11:91.
30. Patel SA, Ramkissoon SH, Bryan M, et al. Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep. 2012;2:906.
31. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17(10):1253-1270.
32. Borjigin M, Strouse B, Niamat RA, et al. Proliferation of genetically modified human cells on electrospun nanofiber scaffolds. Mol Ther Nucleic Acids. 2012;1:e59.
33. Bissell MJ. The differentiated state of normal and malignant cells or how to define a "normal" cell in culture. Int Rev Cytol. 1981;70:27-100.
34. Weigelt B, Bissell MJ. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol. 2008;18(5):311-321.
35. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation. 2002;70(9-10):537-546.
36. Saha S, Duan X, Wu L, Lo PK, Chen H, Wang Q. Electrospun fibrous scaffolds promote breast cancer cell alignment and epithelial-mesenchymal transition. Langmuir. 2012;28(4):2028-2034.
37. Fournier MV, Martin KJ, Kenny PA, et al. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res. 2006;66(14):7095-7102.
38. Anders M, Hansen R, Ding RX, Rauen KA, Bissell MJ, Korn WM. Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci U S A. 2003;100(4):1943-1948.
39. Weaver VM, Lelievre S, Lakins JN, et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell. 2002;2(3):205-216.
40. Gangopadhyay S, Nandy A, Hor P, Mukhopadhyay A. Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer. 2013;13(1): 7-15.
41. Dickson RB, Deb TB. EGF receptor in breast cancer chemoresistance. Adv Exp Med Biol. 2007;608:113-118.
42. Gan Y, Wientjes MG, Au JL. Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors. Pharm Res. 2006;23(6):1324-1331.
43. Polini A, Scaglione S, Quarto R, Pisignano D. Composite electrospun nanofibers for influencing stem cell fate. Methods Mol Biol. 2013;1058: 25-40.
44. Nadri S, Kazemi B, Eslaminejad MB, Yazdani S, Soleimani M. High yield of cells committed to the photoreceptor-like cells from conjunctiva mesenchymal stem cells on nanofibrous scaffolds. Mol Biol Rep. 2013;40(6):3883-3890.
45. Chen L, Xiao Z, Meng Y, et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials. 2012;33(5):1437-1444.